| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...860370G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0060370 |
| P932 | PMC publication ID | 3608602 |
| P698 | PubMed publication ID | 23555960 |
| P5875 | ResearchGate publication ID | 236106817 |
| P50 | author | Gandhi Damaj | Q91137935 |
| Jean-Pierre Marolleau | Q54448958 | ||
| P2093 | author name string | Jean-Pierre Marolleau | |
| Bruno Royer | |||
| Brigitte Gubler | |||
| Hussein Ghamlouch | |||
| Hakim Ouled-Haddou | |||
| P2860 | cites work | Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders | Q71010581 |
| The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia | Q73267557 | ||
| Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia | Q74505894 | ||
| Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis | Q77378789 | ||
| Interleukin-12 inhibits apoptosis in chronic lymphatic leukemia (CLL) B cells | Q78624059 | ||
| CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment | Q80837099 | ||
| A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia | Q84148159 | ||
| Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes | Q24319022 | ||
| Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity | Q28268312 | ||
| Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. | Q33193186 | ||
| Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles | Q33385676 | ||
| In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 | ||
| Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. | Q34029409 | ||
| A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease | Q35029969 | ||
| Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia | Q35553576 | ||
| Protein kinases in the regulation of apoptosis in B-cell chronic lymphocytic leukemia | Q35635542 | ||
| Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha | Q35847913 | ||
| Microenvironmental interactions and survival of CLL B-cells | Q35994836 | ||
| Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch". | Q36825701 | ||
| Cellular immune therapy for chronic lymphocytic leukemia | Q36885803 | ||
| The normal counterpart to the chronic lymphocytic leukemia B cell | Q36914060 | ||
| Germinal centres: role in B-cell physiology and malignancy | Q37039584 | ||
| Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation | Q37328562 | ||
| Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting | Q37795157 | ||
| The role of IL-21 in hematological malignancies | Q37913683 | ||
| Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment | Q39442429 | ||
| The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways | Q40067429 | ||
| Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. | Q40710802 | ||
| Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression | Q41808003 | ||
| Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. | Q42183094 | ||
| Multiplex analysis of cytokines, chemokines, growth factors, MMP-9 and TIMP-1 produced by human bone marrow, adipose tissue, and placental mesenchymal stromal cells | Q42503938 | ||
| Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells | Q42509999 | ||
| Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. | Q42519684 | ||
| Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors. | Q43026682 | ||
| Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. | Q46044632 | ||
| Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia. | Q51560137 | ||
| Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels. | Q53665010 | ||
| Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia | Q58042064 | ||
| Expression of Adhesion Molecules in B-cell Chronic Lymphocytic Leukaemia: an Analysis in Lymphoid Compartments - Peripheral Blood, Bone Marrow and Lymph Node | Q63634112 | ||
| Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro | Q70902052 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | e60370 | |
| P577 | publication date | 2013-03-26 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro | |
| P478 | volume | 8 |
| Q55061968 | A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia. |
| Q33896639 | Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions |
| Q45833017 | B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL. |
| Q38966197 | B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia |
| Q35054626 | Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton. |
| Q52579132 | Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective. |
| Q89896570 | Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role |
| Q37417442 | Cytokine Contents in Chronic Lymphocytic Leukemia: Association with ZAP70 Expression |
| Q36759124 | Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study |
| Q38298483 | Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells |
| Q42367941 | Macrophage-mediated chronic lymphocytic leukemia cell survival is independent of APRIL signaling |
| Q56514276 | Microenvironmental agonists generate phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL |
| Q38984569 | Modeling the chronic lymphocytic leukemia microenvironment in vitro |
| Q34052050 | Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells |
| Q37362593 | STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia. |
| Q35534809 | TACI expression and signaling in chronic lymphocytic leukemia |
| Q33760295 | TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20(+) Antibody-Secreting Cells |
| Q26798062 | Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to date |
| Q38895643 | The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine |
| Q35061209 | ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation |
Search more.